Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A status conference hearing regarding a national talcum powder lawsuit recently took place, moving the baby powder cancer lawsuit closer to trial. Plaintiffs in the talcum powder lawsuit filed in December 2014 claim that use of baby powder products manufactured and sold by Johnson & Johnson and Imerys Talc America caused them to develop ovarian cancer.
These baby powder ovarian cancer allegations allege that the manufacturers concealed risks from consumers and that Johnson & Johnson specifically failed to warn the public of talcum powder’s connection to ovarian cancer.
Fifty plaintiffs took part in the July 14 status conference hearing, which was held to determine which baby powder cancer lawsuits could be resolved before proceeding to trail and which ones would move forward. The results of the baby powder cancerstatus conference hearing presided over by Judge Rex M. Burlison were not disclosed to the public, but the fact that it was held indicates that the baby powder lawsuit is progressing toward a possible trial.
Talcum Powder Studies Provide Evidence for Lawsuit
The plaintiffs in the talcum powder lawsuit claim that defendants Johnson & Johnson and Imerys Talc America knowingly manufactured and sold baby powder products that are allegedly linked to an increased risk of ovarian cancer. The plaintiffs in this baby powder cancer lawsuit have referenced numerous research studies conducted as far back as 1973 that link talcum powder to a higher risk of ovarian cancer.
These studies have demonstrated that when routinely used, talcum powder particles can travel through the female reproductive system to the ovaries. Talc particles may remain in the ovaries for many years, causing inflammation and creating an environment conducive to the growth of cancer cells.
Some studies, including one performed by the medical journal Cancer Prevention Research, have found that regular talcum powder use by women can increase the risk of ovarian cancer by up to 30 percent.
While the FDA outlawed asbestos from talcum powders in 1973, plaintiffs claim that talcum powder still has cancer-causing particles and that the manufacturers ignored the risks, putting women at danger of developing ovarian cancer.
The Talcum Powder Lawsuit is Case No. 1422-CC09326-01, in the City of St. Louis Circuit Court.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. [In general, baby powder cancer lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Baby Powder Cancer Class Action Lawsuit Investigation
If you used Johnson’s Baby Powder, Shower to Shower, or another talcum powder product and were diagnosed with ovarian cancer, you may have a legal claim. Family members of loved ones who died of ovarian cancer can also join. Submit your information now for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
